Publication dates

All regions

1-10 of about 1 300 reports for Phase Iii Clinical Trial

Purchase Reports From Reputable Market Research Publishers

Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] - Global Industry Analysis, Size, Share, Growth, Trends

Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] - Global Industry Analysis, Size, Share, Growth, Trends

  • $ 4 795
  • Industry report
  • February 2014
  • by Transparency Market Research

A rising tide of regulatory expectations, tougher inspection regime and instant need of patient reporting has provided the much needed impetus for the growth of the pharmacovigilance market. An upsurge ...

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Data

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) ...

Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014

Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Data

Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global ...

Pharma Clinical Trial Services: World Market 2013-2023

Pharma Clinical Trial Services: World Market 2013-2023

  • $ 2 401
  • Industry report
  • January 2013
  • by Visiongain

Report Details Discover new trends, opportunities and prospects for contract clinical trials What's the outlook for clinical research providers? Visiongain's updated report gives you forecasted revenues ...

Global CRO Market : Transformation, Developments, Opportunities and Future of CRO Market

Global CRO Market : Transformation, Developments, Opportunities and Future of CRO Market

  • $ 10 000
  • Industry report
  • February 2015
  • by Frost & Sullivan

Key Findings •The global Contract Research Organization (CRO) market was $ x billion in 2014 and is expected to reach $ x billion in 2019, growing at a robust CAGR (2014-2019) of x %. •The penetration ...

CRO Quality Benchmarking - Phase II/III Service Providers (6th edition)

CRO Quality Benchmarking - Phase II/III Service Providers (6th edition)

  • $ 6 800
  • Industry report
  • March 2014
  • by Industry Standard Research

In its 6th year, ISR's “CRO Quality Benchmarking - Phase II/III Service Providers” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents ...

NeuroSigma, Inc. - Product Pipeline Analysis, 2014 Update

NeuroSigma, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary NeuroSigma, Inc. (NeuroSigma) is a medical device company. The company develops and commercializes trigeminal nerve stimulation technology for a variety of neurologic and psychiatric disorders. ...

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

  • $ 3 500
  • Industry report
  • October 2013
  • by GBI Research

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth Summary GBI Research has released the pharmaceutical report “Monoclonal ...

2013 CRO Quality Benchmarking - Phase II/III Service Providers

2013 CRO Quality Benchmarking - Phase II/III Service Providers

  • $ 6 800
  • Industry report
  • April 2013
  • by Industry Standard Research

Industry Standard Research's (ISR) “2013 CRO Quality Benchmarking - Phase II/III Service Providers” report provides pharmaceutical sponsors and clinical service providers with an independent and comprehensive ...

Hepatitis C Market & Forecast, HCV Drugs Clinical Trials, Hepatitis C Pipeline Drugs Sales & Forecast - Worldwide

Hepatitis C Market & Forecast, HCV Drugs Clinical Trials, Hepatitis C Pipeline Drugs Sales & Forecast - Worldwide

  • $ 1 290
  • Industry report
  • July 2013
  • by Renub Research

Hepatitis C Market Overview Hepatitis C market by 2018 is expected to grow more than 3 times from its current market size of 2012. Hepatitis C virus (HCV) infection is a complex public health problem, ...

About 4 200 reports for Phase Iii Clinical Trial

Download Unlimited Documents from Trusted Public Sources

Medinet Annual Report 2013

  • January 2013
    171 pages
  • Equity Market  

    Preferred Stock  

    Common Stock  

  • United States  

View report >

35 Companies for Phase Iii Clinical Trial

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.